Apimeds Pharmaceuticals Inc. Revenue

Revenue Gross Profit Operating Income EBITDA Net Income EPS Shares Outstanding

No data available.

Apimeds Pharmaceuticals Inc. (APUS) — Frequently Asked Questions

Apimeds Pharmaceuticals Inc. (APUS) is a publicly traded US company. Explore APUS's stock price, financial statements, earnings history, margins and key ratios below.

What is the APUS stock price?

APUS trades at $1.29 (-1.53% on the day).